-transparent.png){kind=logo}
We studied the effect of the standard oral dose (160 mg/d) of megestrol acetate on the weight gain of 115 advanced cancer patients. All were underweight and were receiving only supportive or symptomatic care. The median treatment time was 74 weeks (range: 4 weeks to 2 years). The mean body weight gain of all patients was 4.84 kg (range: -3 to 18 kg) regardless of the disease status. Weight gain was dependent on the length of treatment time. The performance status after therapy also shifted to the better status with significant statistical difference. All patients felt an increase of appetite and also had an improved sense of well-being. No serious side-effects of the treatment were noted in this study.
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
November 1978,
Urology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
August 1990,
Onkologie,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
February 1982,
Cancer,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
March 1986,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
April 1988,
Seminars in oncology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
August 1994,
Anales de medicina interna (Madrid, Spain : 1984),
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
April 1988,
Seminars in oncology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
February 1985,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
April 1988,
Seminars in oncology,
P Tepmongkol, and
K Chongsiriwat, and
A Thansakul
December 1986,
Seminars in oncology,
